HCM Marketplace

WEBCAST ON CD Sponsored byCompliance Speedway

presented on November 15, 2007

States are focusing more and more on gifts pharmaceutical companies give to prescribers. Where your organization is based, where you do business, and how you track your gifts are all major factors in the statutes that apply to your organization, and the scrutiny you can expect from regulators. Penalties for non-compliance are high, and with each individual incident punishable by a separate fine, the cost of being sloppy is steep.

As budget planning for the new year begins, you need to know how best to allocate your organization’s gift-giving dollars and remain in compliance with state-specific rules. You need to consider how you can effectively track gift-reporting rules and how to predict which rules will affect your organization in the future.

Prepare for future regulation

Listen to HCPro's 60-minute webcast “Gift Reporting: Navigate state-specific rules to avoid conflicts of interest.” Legal advisors Bruce Armon and Tanya Berlage, attorneys with Saul Ewing LLP, and Eileen May, senior director of operations for ADVOGENT, provide practical strategies you can use to help your company avoid costly mistakes. Discussion focuses on the states where restrictions are in place, and how these statutes may impact provisions in other states.

At the end of this audioconference, you will be able to:

• Recognize proactive steps for handling gift reporting compliance issues
• Integrate tips and best practices for the reporting and tracking of gifts
• Illustrate an awareness of existing state-specific gift reporting requirements
• Predict future state-specific gift reporting rules

AGENDA

• Gift reporting
  • Ongoing compliance issues
  • Planning for the future
• State-specific examples
  • D.C., Maine, Minnesota, West Virginia, and Vermont
  • Legal concerns
  • Contract partners
• Tips and preventative measures
  • Strategies for reporting and tracking gifts
  • Proposed federal initiatives
  • Upcoming state initiatives
  • How state laws differ from PhRMA code and other existing safeguards.
• Question & Answer Session

MEET THE SPEAKERS

Bruce D. Armon, Esq., is a Partner in Saul Ewing's Business Department in its Philadelphia office, and Chair of the Life Science's Practice Group. He concentrates his practice in corporate healthcare law. Mr. Armon has assisted pharmaceutical companies and product manufacturers, physicians, dentists, ancillary providers and hospitals in a variety of statutory, compliance, contractual and regulatory matters.

Tanya D. Berlage, Esq., is a Partner in Saul Ewing’s Life Sciences Practice Group, and represents clients in the pharmaceutical, biotech and medical device industries. Previously, Berlage served as Vice President, Chief Counsel, North America for Taro Pharmaceuticals U.S.A., Inc., where she worked on matters involving all stages of the pharmaceutical product life cycle, from product development and approval to manufacturing, sales, marketing and distribution.

Eileen J. May, is the Senior Director of Operations at ADVOGENT. Her responsibilities include operational change management, new business implementation and defining and deploying corporate standard operating procedures. Previously, May spent six years in Operations Management directing the Operations organization for multiple pharmaceutical customers.

WHO SHOULD LISTEN?

• Compliance officers in pharmaceutical companies
• In-house attorneys for pharmaceutical companies
• Sales and marketing personnel responsible for setting and enforcing gift policies
• Third-party vendors who work with pharmaceutical companies

Program Materials

You will receive presentation slides, and other materials that you can print and distribute to all of your peers at your location. Purchase a CD of the program and listen when you can. It's also a perfect training tool for new staff or as a refresher for veteran staff.

• Webcasts

• Other Life Sciences Products